Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Karl Lewis"'
Autor:
Melissa Johnson, Arkadiusz Z. Dudek, Ammar Sukari, Justin Call, Paul R. Kunk, Karl Lewis, Justin F. Gainor, John Sarantopoulos, Patrice Lee, Adele Golden, Allison Harney, S. Michael Rothenberg, Yuanyuan Zhang, Jonathan W. Goldman
Publikováno v:
Clinical Cancer Research. 28:2517-2526
Purpose: ARRY-382 (PF-07265804) is a selective inhibitor of colony-stimulating factor-1 receptor. We evaluated the safety and preliminary efficacy of ARRY-382 plus pembrolizumab in patients with advanced solid tumors. Patients and Methods: This was a
Autor:
Ralf, Gutzmer, Daniil, Stroyakovskiy, Helen, Gogas, Caroline, Robert, Karl, Lewis, Svetlana, Protsenko, Rodrigo P, Pereira, Thomas, Eigentler, Piotr, Rutkowski, Lev, Demidov, Georgy Moiseevich, Manikhas, Yibing, Yan, Kuan-Chieh, Huang, Anne, Uyei, Virginia, McNally, Grant A, McArthur, Paolo A, Ascierto
Publikováno v:
Lancet (London, England). 395(10240)
IMspire150 aimed to evaluate first-line combination treatment with BRAF plus MEK inhibitors and immune checkpoint therapy in BRAFIMspire150 was a randomised, double-blind, placebo-controlled phase 3 study done at 112 institutes in 20 countries. Patie
Autor:
Dirk, Schadendorf, Anna Maria, Di Giacomo, Lev, Demidov, Barbara, Merelli, Igor, Bondarenko, Paolo A, Ascierto, Christopher, Herbert, Andrzej, Mackiewicz, Piotr, Rutkowski, Alexander, Guminski, Grant R, Goodman, Brian, Simmons, Chenglin, Ye, Agnes, Hong, Karl, Lewis
Publikováno v:
European journal of cancer (Oxford, England : 1990). 123
The aim of the study was to assess the impact of treatment with adjuvant vemurafenib monotherapy on health-related quality of life (HRQOL) in patients with resected stage IIC-IIIC melanoma.The phase 3 BRIM8 study (NCT01667419) randomised patients wit
Autor:
Karl, Lewis, Axel, Hauschild, James, Larkin, Antoni, Ribas, Keith T, Flaherty, Grant A, McArthur, Brigitte, Dréno, Edward, McKenna, Qian, Zhu, Yong, Mun, Paolo A, Ascierto
Publikováno v:
European journal of cancer (Oxford, England : 1990). 116
We conducted a retrospective analysis to evaluate the impact of concomitant acid-reducing agents (ARAs) and vemurafenib dose on the efficacy of vemurafenib in patients with BRAFData were pooled for patients treated with vemurafenib or cobimetinib plu
Autor:
Ragini, Kudchadkar, Rene, Gonzalez, Karl, Lewis, Krista, Treichel, Susan, Hammerman, William, Robinson, James, Fitzpatrick, Ricardo, Gonzalez, Brian, Kavanagh, Kyle, Rusthoven
Publikováno v:
Oncology (Williston Park, N.Y.). 22(3)
Publikováno v:
The American surgeon. 72(4)
A patient undergoing evaluation for malignant melanoma was thought to have a metastatic process involving the anterior mediastinum, axilla, spleen, and possibly liver based on radiologic findings from positron emission tomography and computed tomogra